1. Home
  2. News
  3. Nanjing Vazyme Biotech Co., Ltd.
  4. Announcement on Preliminary Earnings Estimate for 2025
More Nanjing Vazyme Biotech Co., Ltd. news
Nanjing Vazyme Biotech Co., Ltd.SSE: 688105

Announcement on Preliminary Earnings Estimate for 2025

Feb 27, 2026 · Issued by Nanjing Vazyme Biotech Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Feb 27, 2026 · 2 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-preliminary-earnings-estimate-for-2025-82

Nanjing Vazyme Biotech Co., Ltd. on 6ix

Earlier from Nanjing Vazyme Biotech

  • Announcement on Estimated Daily Related Party Transactions in 2026Feb 12
  • Earnings Preannouncement for 2025Jan 30
  • Announcement on Expiration of Shareholding Reduction Plan and Results of ShareholdersDec 25, 2025
  • Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% ScaleDec 23, 2025
  • Announcement on Voluntary Disclosure of Obtaining EU CE IVDR Certification for the Company's ProductsDec 18, 2025

Later from Nanjing Vazyme Biotech

  • Announcement on Progress in Repurchasing Shares through Call AuctionMar 3
  • Announcement on Implementation Result of Shares Repurchase and Share ChangesApr 3
  • Announcement on Resolutions of the 22nd Meeting of the 2nd Board of DirectorsApr 23
  • Announcement on Resolutions of the 2025 Annual General MeetingMay 14
  • Notice on Convening the 1st Extraordinary General Meeting in 2026May 19
All Nanjing Vazyme Biotech news releases↗

Follow Nanjing Vazyme Biotech into a list and get an email when it puts out news.

Follow Nanjing Vazyme Biotech
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer